疫苗接种-话题@MedSci

#疫苗接种#

377篇内容 | 7602人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1258148, encodeId=563f1258148f6, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2022年3月11日简报：本土连续新冠病毒感染超500人；德国韩国日增均超30万，均创新高，欧洲多国疫情重新抬头；日本预计今夏开放第四剂新冠疫苗接种, objectType=article, longId=300493, objectId=748f300493a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=748f300493a9, replyNumber=0, likeNumber=79, createdTime=2022-03-12, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=748f300493a9, moduleTitle=2022年3月11日简报：本土连续新冠病毒感染超500人；德国韩国日增均超30万，均创新高，欧洲多国疫情重新抬头；日本预计今夏开放第四剂新冠疫苗接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=748f300493a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258147, encodeId=1b22125814ebc, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=NEJM：美国北卡罗来纳州新冠肺炎疫苗接种后9个月疗效评估, objectType=article, longId=300466, objectId=b6b430046629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6b430046629, replyNumber=0, likeNumber=109, createdTime=2022-03-12, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6b430046629, moduleTitle=NEJM：美国北卡罗来纳州新冠肺炎疫苗接种后9个月疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6b430046629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258146, encodeId=2dc51258146bf, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=NEJM：单次Ad26.COV2.S疫苗接种后新冠肺炎防效可达52%, objectType=article, longId=300284, objectId=484030028432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=484030028432, replyNumber=0, likeNumber=89, createdTime=2022-03-10, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=484030028432, moduleTitle=NEJM：单次Ad26.COV2.S疫苗接种后新冠肺炎防效可达52%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=484030028432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258144, encodeId=a36b125814487, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2022年3月6日简报：香港新增新冠肺炎确诊病例37529例，12岁以上人群首针新冠疫苗接种率达九成；韩国累计新冠肺炎确诊病例突破400万例, objectType=article, longId=300156, objectId=ee7f30015612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7f30015612, replyNumber=0, likeNumber=85, createdTime=2022-03-07, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7f30015612, moduleTitle=2022年3月6日简报：香港新增新冠肺炎确诊病例37529例，12岁以上人群首针新冠疫苗接种率达九成；韩国累计新冠肺炎确诊病例突破400万例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7f30015612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258143, encodeId=50dc12581433c, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2022年2月26日简报：香港新增10010例新冠肺炎确诊病例；全国新冠疫苗接种超31亿剂次；全球主要发达国家疫情明显好转, objectType=article, longId=299682, objectId=e10329968242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e10329968242, replyNumber=0, likeNumber=91, createdTime=2022-02-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e10329968242, moduleTitle=2022年2月26日简报：香港新增10010例新冠肺炎确诊病例；全国新冠疫苗接种超31亿剂次；全球主要发达国家疫情明显好转, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e10329968242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258145, encodeId=73e61258145df, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=MMWR Morb Mortal Wkly Rep：根据性取向和性别身份确定的COVID-19疫苗接种覆盖率和疫苗接种信心, objectType=article, longId=299603, objectId=f7a7299603f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a7299603f9, replyNumber=0, likeNumber=72, createdTime=2022-02-26, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a7299603f9, moduleTitle=MMWR Morb Mortal Wkly Rep：根据性取向和性别身份确定的COVID-19疫苗接种覆盖率和疫苗接种信心, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7a7299603f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258142, encodeId=977b12581420a, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=NEJM：Covid-19疫苗接种对Alpha和Delta变异株传播能力的影响, objectType=article, longId=299571, objectId=c5b12995e1e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5b12995e1e5, replyNumber=0, likeNumber=72, createdTime=2022-02-25, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5b12995e1e5, moduleTitle=NEJM：Covid-19疫苗接种对Alpha和Delta变异株传播能力的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5b12995e1e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258141, encodeId=c8801258141f3, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=2022年2月21日简报：香港80岁以上老人超过40万，完成疫苗接种仅27.58%，令人担忧；昨日再增6000多例本土病例，病亡14人；美疾控中心未公布其收集的大部分新冠疫情数据, objectType=article, longId=299307, objectId=d1e729930eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1e729930eec, replyNumber=0, likeNumber=89, createdTime=2022-02-22, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1e729930eec, moduleTitle=2022年2月21日简报：香港80岁以上老人超过40万，完成疫苗接种仅27.58%，令人担忧；昨日再增6000多例本土病例，病亡14人；美疾控中心未公布其收集的大部分新冠疫情数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1e729930eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258140, encodeId=db421258140a1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=JCI：SARS-CoV-2感染和疫苗接种对免疫记忆和加强策略的影响, objectType=article, longId=295647, objectId=157929564ee3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=157929564ee3, replyNumber=0, likeNumber=80, createdTime=2022-02-16, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=157929564ee3, moduleTitle=JCI：SARS-CoV-2感染和疫苗接种对免疫记忆和加强策略的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=157929564ee3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258139, encodeId=e2331258139cc, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=JEADV：BNT162b2疫苗接种SARS-CoV-2后重症寻常型天疱疮的发生, objectType=article, longId=294980, objectId=71b3294980b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71b3294980b1, replyNumber=0, likeNumber=90, createdTime=2022-02-02, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71b3294980b1, moduleTitle=JEADV：BNT162b2疫苗接种SARS-CoV-2后重症寻常型天疱疮的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71b3294980b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258138, encodeId=20b8125813831, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=JAMA：与辉瑞相比，Moderna的mRNA疫苗接种后突破性感染更少，住院更少, objectType=article, longId=294484, objectId=d81c294484b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d81c294484b9, replyNumber=0, likeNumber=63, createdTime=2022-01-23, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d81c294484b9, moduleTitle=JAMA：与辉瑞相比，Moderna的mRNA疫苗接种后突破性感染更少，住院更少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d81c294484b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258137, encodeId=4596125813ef4, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=NEJM：ChAdOx1-S疫苗和BNT162b2疫苗接种后20周疫苗效果开始下降, objectType=article, longId=294148, objectId=c35629414864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c35629414864, replyNumber=0, likeNumber=80, createdTime=2022-01-19, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c35629414864, moduleTitle=NEJM：ChAdOx1-S疫苗和BNT162b2疫苗接种后20周疫苗效果开始下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c35629414864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258136, encodeId=f5591258136e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=Nat Med：孕妇COVID-19疫苗接种与SARS-CoV-2感染, objectType=article, longId=293981, objectId=31ae29398138, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ae29398138, replyNumber=0, likeNumber=102, createdTime=2022-01-16, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ae29398138, moduleTitle=Nat Med：孕妇COVID-19疫苗接种与SARS-CoV-2感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ae29398138)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258135, encodeId=ba31125813594, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=JAMA Intern Med：SARS-CoV-2疫苗接种后免疫功能障碍与COVID-19突破性感染的相关性, objectType=article, longId=293882, objectId=584029388253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=584029388253, replyNumber=0, likeNumber=74, createdTime=2022-01-13, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=584029388253, moduleTitle=JAMA Intern Med：SARS-CoV-2疫苗接种后免疫功能障碍与COVID-19突破性感染的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=584029388253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258134, encodeId=2f48125813461, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=张文宏：已看到漫漫长夜的曙光，关键是疫苗接种率和病死率控制得很低, objectType=article, longId=293620, objectId=5ebb29362050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ebb29362050, replyNumber=0, likeNumber=68, createdTime=2022-01-10, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ebb29362050, moduleTitle=张文宏：已看到漫漫长夜的曙光，关键是疫苗接种率和病死率控制得很低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ebb29362050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258132, encodeId=e3e2125813273, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=JAMA Netw Open：母亲宫颈疾病与后代人乳头瘤病毒疫苗接种的关系, objectType=article, longId=293511, objectId=c36c2935113d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c36c2935113d, replyNumber=0, likeNumber=130, createdTime=2022-01-07, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c36c2935113d, moduleTitle=JAMA Netw Open：母亲宫颈疾病与后代人乳头瘤病毒疫苗接种的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c36c2935113d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258133, encodeId=63e212581334b, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=Neurology：4种SARS-CoV-2疫苗接种后脑静脉窦血栓形成风险一览，年轻人群首当其冲, objectType=article, longId=293441, objectId=3943293441b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3943293441b7, replyNumber=0, likeNumber=78, createdTime=2022-01-06, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3943293441b7, moduleTitle=Neurology：4种SARS-CoV-2疫苗接种后脑静脉窦血栓形成风险一览，年轻人群首当其冲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3943293441b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258131, encodeId=57b9125813185, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=N Engl J Med：第三针BNT162b2疫苗接种对Omicron中和效果如何, objectType=article, longId=293174, objectId=5ae82931e483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae82931e483, replyNumber=0, likeNumber=86, createdTime=2022-01-01, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae82931e483, moduleTitle=N Engl J Med：第三针BNT162b2疫苗接种对Omicron中和效果如何, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ae82931e483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258130, encodeId=151a12581305e, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=AJH：接受鲁索替尼治疗的骨髓增殖性肿瘤患者对首次 SARS-CoV-2 疫苗接种的反应受损, objectType=article, longId=293129, objectId=4f8329312916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8329312916, replyNumber=0, likeNumber=129, createdTime=2021-12-31, rootId=0, userName=lishiwen, userId=5c0050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8329312916, moduleTitle=AJH：接受鲁索替尼治疗的骨髓增殖性肿瘤患者对首次 SARS-CoV-2 疫苗接种的反应受损, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8329312916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1258128, encodeId=f7c0125812873, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, objectTitle=ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应, objectType=article, longId=292826, objectId=692329282612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=692329282612, replyNumber=0, likeNumber=92, createdTime=2021-12-29, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=692329282612, moduleTitle=ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=692329282612)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疫苗接种

2020-05-29发表于上海

lishiwen

#疫苗接种#

2022年3月11日简报：本土连续新冠病毒感染超500人；德国韩国日增均超30万，均创新高，欧洲多国疫情重新抬头；日本预计今夏开放第四剂新冠疫苗接种

2022-03-12

lishiwen

#疫苗接种#

NEJM：美国北卡罗来纳州新冠肺炎疫苗接种后9个月疗效评估

2022-03-12

lishiwen

#疫苗接种#

NEJM：单次Ad26.COV2.S疫苗接种后新冠肺炎防效可达52%

2022-03-10

lishiwen

#疫苗接种#

2022年3月6日简报：香港新增新冠肺炎确诊病例37529例，12岁以上人群首针新冠疫苗接种率达九成；韩国累计新冠肺炎确诊病例突破400万例

2022-03-07

zhouqu_8

#疫苗接种#

2022年2月26日简报：香港新增10010例新冠肺炎确诊病例；全国新冠疫苗接种超31亿剂次；全球主要发达国家疫情明显好转

2022-02-27

lishiwen

#疫苗接种#

MMWR Morb Mortal Wkly Rep：根据性取向和性别身份确定的COVID-19疫苗接种覆盖率和疫苗接种信心

2022-02-26

lishiwen

#疫苗接种#

NEJM：Covid-19疫苗接种对Alpha和Delta变异株传播能力的影响

2022-02-25

lishiwen

#疫苗接种#

2022年2月21日简报：香港80岁以上老人超过40万，完成疫苗接种仅27.58%，令人担忧；昨日再增6000多例本土病例，病亡14人；美疾控中心未公布其收集的大部分新冠疫情数据

2022-02-22

lishiwen

#疫苗接种#

JCI：SARS-CoV-2感染和疫苗接种对免疫记忆和加强策略的影响

2022-02-16

lishiwen

#疫苗接种#

JEADV：BNT162b2疫苗接种SARS-CoV-2后重症寻常型天疱疮的发生

2022-02-02

lishiwen

#疫苗接种#

JAMA：与辉瑞相比，Moderna的mRNA疫苗接种后突破性感染更少，住院更少

2022-01-23

lishiwen

#疫苗接种#

NEJM：ChAdOx1-S疫苗和BNT162b2疫苗接种后20周疫苗效果开始下降

2022-01-19

lishiwen

#疫苗接种#

Nat Med：孕妇COVID-19疫苗接种与SARS-CoV-2感染

2022-01-16

zhaojie88

#疫苗接种#

JAMA Intern Med：SARS-CoV-2疫苗接种后免疫功能障碍与COVID-19突破性感染的相关性

2022-01-13

lishiwen

#疫苗接种#

张文宏：已看到漫漫长夜的曙光，关键是疫苗接种率和病死率控制得很低

2022-01-10

lishiwen

#疫苗接种#

JAMA Netw Open：母亲宫颈疾病与后代人乳头瘤病毒疫苗接种的关系

2022-01-07

lishiwen

#疫苗接种#

Neurology：4种SARS-CoV-2疫苗接种后脑静脉窦血栓形成风险一览，年轻人群首当其冲

2022-01-06

lishiwen

#疫苗接种#

N Engl J Med：第三针BNT162b2疫苗接种对Omicron中和效果如何

2022-01-01

lishiwen

#疫苗接种#

AJH：接受鲁索替尼治疗的骨髓增殖性肿瘤患者对首次 SARS-CoV-2 疫苗接种的反应受损

2021-12-31

仁心济世

#疫苗接种#

ARD：B细胞耗竭以I型干扰素依赖性方式损害疫苗接种诱导的CD8+ T细胞反应

2021-12-29

科室
- - 订阅+
  - 更多科室
工具
服务